Article info

Download PDFPDF

Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations

Authors

  1. a jgong{at}coh.org
  2. b Achehrazi-raffle{at}dhs.lacounty.gov
  3. c SReddi{at}dhs.lacounty.gov
  4. d 626-256-4673 rsalgia{at}coh.org
View Full Text

Citation

Gong J, Chehrazi-Raffle A, Reddi S, et al
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations

Publication history

  • Received October 22, 2017
  • Accepted January 9, 2018
  • First published January 23, 2018.
Online issue publication 
January 23, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.